MDR · ASX

MedAdvisor Limited (ASX:MDR)

AU$0.058

 -0.002 (-3.333%)
ASX:Live
22/08/2025 03:51:36 PM
HALO Ords HALO Consensus Value GROWTH AUS Consensus Cheap All-Consensus +1
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

MDR Overview

MDR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About MDR

Website

MedAdvisor Limited

Telephone

61.3.9095.3036

Address

Level 2 971 Burke Road Camberwell, Victoria (VIC) 3124

Description

MedAdvisor Ltd. engages in the provision of pharmacy-driven, innovative patient engagement solutions that simplify the patient medication journey to empower better health. It operates through the following segments: Australia and New Zealand Operations, the United States Operations, the United Kingdom Operations, Asia Operations, and Corporate. The company was founded by Joshua Swinnerton in 2010 and is headquartered in Camberwell, Australia.

MDR Price Chart

Key Stats

Market Cap

AU$37.52M

PE

43.00

EV/EBITDA

34.9

Dividends Overview

DIV Yield

.0%

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.05 - 0.49

Trade Value (12mth)

AU$34,408.00

1 week

-4.76%

1 month

-25%

YTD

-73.91%

1 year

-86.96%

All time high

1.73

Key Fundamentals

EPS 3 yr Growth

-103.20%

EBITDA Margin

5.60%

Operating Cashflow

$5m

Free Cash Flow Return

9.20%

ROIC

1.40%

Interest Coverage

3.60

Quick Ratio

0.70

Other Data

Shares on Issue (Fully Dilluted)

604m

HALO Sector

Technology

Next Company Report Date

27-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.01

MDR Announcements

Latest Announcements

Date Announcements

21 August 25

General Meeting - Results of Meeting

×

General Meeting - Results of Meeting

06 August 25

MedAdvisor Quarterly Activities Report 4Q FY25 - Addendum

×

MedAdvisor Quarterly Activities Report 4Q FY25 - Addendum

31 July 25

MDR 4Q FY25 Quarterly Activity Report and 4C

×

MDR 4Q FY25 Quarterly Activity Report and 4C

31 July 25

MDR 4Q FY25 Investor Presentation

×

MDR 4Q FY25 Investor Presentation

30 July 25

MedAdvisor Investor Webinar Invitation

×

MedAdvisor Investor Webinar Invitation

22 July 25

Notice of Extraordinary General Meeting

×

Notice of Extraordinary General Meeting

18 July 25

Notification regarding unquoted securities - MDR

×

Notification regarding unquoted securities - MDR

17 July 25

Appointment of CFO and Company Secretary

×

Appointment of CFO and Company Secretary

11 July 25

Application for quotation of securities - MDR

×

Application for quotation of securities - MDR

09 July 25

Change in substantial holding

×

Change in substantial holding

07 July 25

Completion of Sale of ANZ Business Operations

×

Completion of Sale of ANZ Business Operations

07 July 25

MedAdvisor Investor Webinar Invitation

×

MedAdvisor Investor Webinar Invitation

02 July 25

Sale of ANZ Business Operations Update

×

Sale of ANZ Business Operations Update

05 June 25

Change in substantial holding

×

Change in substantial holding

20 May 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

19 May 25

Application for quotation of securities - MDR

×

Application for quotation of securities - MDR

16 May 25

Notice of change of interests of substantial holder from EBO

×

Notice of change of interests of substantial holder from EBO

15 May 25

Successful Completion of Share Purchase Plan

×

Successful Completion of Share Purchase Plan

15 May 25

Application for quotation of securities - MDR

×

Application for quotation of securities - MDR

09 May 25

Strategic Review Update - Further Information

×

Strategic Review Update - Further Information

07 May 25

Evaluation of Strategic Options Update

×

Evaluation of Strategic Options Update

07 May 25

Pause in Trading

×

Pause in Trading

07 May 25

Trading Halt

×

Trading Halt

02 May 25

Court Orders Granted & Trading to Resume

×

Court Orders Granted & Trading to Resume

02 May 25

Reinstatement to Official Quotation

×

Reinstatement to Official Quotation

MDR Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.05 -0.02 0.00 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.05 -0.02 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -4.1 54.7 106.7 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A 55.4 43.0 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A 15.9 34.9 Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.03 -0.01 0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 -0.00 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -61.9 74.0 288.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock -0.9 -1.2 1.7 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A 0.0 0.0 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.09 0.11 0.09 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock -0.06 -0.04 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -254.3 28.9 40.8 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 378 545 597 Lock Lock Lock
Basic m Lock Lock Lock Lock 378 545 548 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 68 98 122 Lock Lock Lock
     Growth % Lock Lock Lock Lock 74.7 44.6 24.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 14 20 21 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -2 13 24 Lock Lock Lock
     Growth % Lock Lock Lock Lock 69.6 783.3 87.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2.7 12.8 19.4 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 103 87 81 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -11 -2 7 Lock Lock Lock
     Growth % Lock Lock Lock Lock 25.2 79.1 391.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -16.7 -2.4 5.6 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 5 5 4 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -16 -8 3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 11.6 52.3 134.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -23.9 -7.9 2.2 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -18 -11 1 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 1 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -17 -11 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -24.4 34.8 107.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -25.6 -11.5 0.6 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 0 -1 5 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 2 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 -3 -3 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 2 12 -1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -1 -2 5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 95.8 -197.9 413.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.0 -0.0 0.0 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 8 14 16 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 78 96 99 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 8 12 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 6 -1 -3 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 44 47 47 Lock Lock Lock
Equity $m Lock Lock Lock Lock 35 48 52 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 43 61 52 Lock Lock Lock
     Growth % Lock Lock Lock Lock -24.2 43.0 -15.1 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -22.1 -11.8 0.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -50.2 -23.3 1.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -30.6 -14.1 4.3 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -35.2 -21.9 1.4 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -0.5 -2.8 9.2 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -7.3 -1.1 3.6 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -0.5 0.5 -0.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 16.9 -2.3 -5.8 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 0.5 0.8 0.7 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.5 0.8 0.7 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 41.0 50.5 47.9 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -0.7 -4.4 11.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 6.3 9.4 9.2 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 8.9 4.3 2.7 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.9 1.0 1.2 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.9 1.0 1.2 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -26.2 -10.7 0.8 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -22.6 -11.0 0.9 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 14.2 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -22.1 -11.8 0.8 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.3 2.0 1.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -50.2 -23.3 1.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -50.2 -23.3 1.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 58.0 38.7 39.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 58.0 38.7 39.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 25.7 21.7 13.8 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 32.3 17.0 25.9 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.0%

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.08%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

0.10%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

MDR Shortsell

Frequently Asked Questions

The current share price of MedAdvisor Limited (MDR:ASX) is AU$0.058.
The 52-week high share price for MedAdvisor Limited (MDR:ASX) is AU$0.49.
The 52-week low share price for MedAdvisor Limited (MDR:ASX)? is AU$0.05.
The current TTM dividend payout for MedAdvisor Limited (MDR:ASX) is 0.00.
MedAdvisor Limited (MDR:ASX) does not pay a dividend.
MedAdvisor Limited (MDR:ASX) has a franking level of 0.0%.
MedAdvisor Limited (MDR:ASX) is classified in the Technology.
The current P/E ratio for MedAdvisor Limited (MDR:ASX) is 43.00.
The current share price of MedAdvisor Limited (MDR:ASX) is AU$0.058.
The 52-week high share price for MedAdvisor Limited (MDR:ASX) is AU$0.49.
The 52-week low share price for MedAdvisor Limited (MDR:ASX)? is AU$0.05.
The current TTM dividend payout for MedAdvisor Limited (MDR:ASX) is 0.00.
MedAdvisor Limited (MDR:ASX) does not pay a dividend.
MedAdvisor Limited (MDR:ASX) has a franking level of 0.0%.
MedAdvisor Limited (MDR:ASX) is classified in the Technology.
The current P/E ratio for MedAdvisor Limited (MDR:ASX) is 43.00.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.